UBS Group’s Celularity CELU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38K | Hold |
1,215
| – | – | ﹤0.01% | 8157 |
|
|
2025
Q1 | $2.1K | Hold |
1,215
| – | – | ﹤0.01% | 8073 |
|
|
2024
Q4 | $2.53K | Sell |
1,215
-4,802
| -80% | -$9.99K | ﹤0.01% | 7788 |
|
|
2024
Q3 | $17.9K | Buy |
6,017
+4,802
| +395% | +$14.3K | ﹤0.01% | 6224 |
|
|
2024
Q2 | $3.8K | Sell |
1,215
-2
| -0.2% | -$6 | ﹤0.01% | 7010 |
|
|
2024
Q1 | $6.37K | Hold |
1,217
| – | – | ﹤0.01% | 6292 |
|
|
2023
Q4 | $3.01K | Sell |
1,217
-39
| -3% | -$96 | ﹤0.01% | 6811 |
|
|
2023
Q3 | $2.79K | Sell |
1,256
-385
| -23% | -$855 | ﹤0.01% | 6500 |
|
|
2023
Q2 | $8.75K | Sell |
1,641
-1,641
| -50% | -$8.75K | ﹤0.01% | 6137 |
|
|
2023
Q1 | $20.3K | Buy |
3,282
+1,811
| +123% | +$11.2K | ﹤0.01% | 5973 |
|
|
2022
Q4 | $19K | Buy |
1,471
+780
| +113% | +$10.1K | ﹤0.01% | 6526 |
|
|
2022
Q3 | $16K | Sell |
691
-339
| -33% | -$7.85K | ﹤0.01% | 6579 |
|
|
2022
Q2 | $36K | Buy |
1,030
+659
| +178% | +$23K | ﹤0.01% | 5162 |
|
|
2022
Q1 | $32K | Sell |
371
-306
| -45% | -$26.4K | ﹤0.01% | 5885 |
|
|
2021
Q4 | $35K | Buy |
677
+387
| +133% | +$20K | ﹤0.01% | 6118 |
|
|
2021
Q3 | $21K | Buy |
290
+203
| +233% | +$14.7K | ﹤0.01% | 5970 |
|
|
2021
Q2 | $9K | Sell |
87
-245
| -74% | -$25.3K | ﹤0.01% | 7024 |
|
|
2021
Q1 | $33K | Buy |
332
+228
| +219% | +$22.7K | ﹤0.01% | 5909 |
|
|
2020
Q4 | $11K | Buy |
104
+94
| +940% | +$9.94K | ﹤0.01% | 6374 |
|
|
2020
Q3 | $1K | Sell |
10
-1
| -9% | -$100 | ﹤0.01% | 6878 |
|
|
2020
Q2 | $1K | Sell |
11
-3
| -21% | -$273 | ﹤0.01% | 6882 |
|
|
2020
Q1 | $1K | Sell |
14
-1,236
| -99% | -$88.3K | ﹤0.01% | 6813 |
|
|
2019
Q4 | $124K | Buy |
+1,250
| New | +$124K | ﹤0.01% | 4866 |
|